ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CL2888A |
|
905854-03-7 |
(3S,4S)-Tivantinib | 3S,4S)-ARQ 197 | ARQ 198 98+% |
C23H19N3O2 | |
CL2884 |
|
936091-14-4 |
TG101209 98+% |
C26H35N7O2S | |
CL1006C |
|
2109414-84-6 |
Laduviglusib dihydrochloride | CHIR-99021 dihydrochloride | CT99021 dihydrochloride 98+% |
C22H18Cl2N8·2HCl | |
CL2733A |
|
2109704-99-4 |
Belumosudil mesylate (KD025 mesylate; SLx-2119 mesylate) 98+% |
C27H28N6O5S | |
CL2709 |
|
1422144-42-0 |
Netarsudil dimesylate ( AR-13324 dimesylate) 98+% |
C30H35N3O9S2 | |
CL2247A |
|
2050057-56-0 |
Upadacitinib hemihydrate 98+% |
C34H40F6N12O3 | |
CL2693 |
|
1792180-81-4 |
Ritlecitinib 98+% |
C15H19N5O | |
CL2693A |
|
2192215-81-7 |
Ritlecitinib Tosylate 98+% |
C22H27N5O4S | |
CL2655 |
|
1263774-59-9 |
Delgocitinib | JTE-052 | Corectim 98+% |
C16H18N6O | |
CL2547 |
|
83280-65-3 |
Napabucasin(BBI608) 98+% |
C14H8O4 | |
CL2531 |
|
1640292-55-2 |
Oclacitinib Maleate (PF-03394197 Maleate) 98+% |
C19H27N5O6S | |
CL2506 |
|
40391-99-9 |
Pamidronic Acid
|
C3H11NO7P2 | |
CL1014B |
|
485-19-8 |
Reticuline 98+% |
C19H23NO4 | |
CL2425 |
|
425386-60-3 |
Semagacestat (LY450139) 98+% |
C19H27N3O4 | |
CLA1355 |
|
1447814-75-6 |
Brontictuzumab (Anti-NOTCH1) 95+% |
— | |
CLA1337 |
|
1345009-45-1 |
Vantictumab (Anti-FZD) 95+% |
— | |
CLA1334 |
|
1359940-55-8 |
Tarextumab (Anti-NOTCH3) 95+% |
— | |
CLA1299 |
|
1243262-17-0 |
Demcizumab (Anti-DLL4) 95+% |
— | |
CL2221 |
|
1226056-71-8 |
Thiazovivin 98+% |
C15H13N5OS | |
HL1389 |
|
88495-63-0 |
Artesunate 98+% |
C19H28O8 | |